Dipok Kumer Shill
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: University of Dhaka (2020); International Centre for Diarrhoeal Disease Research (2020–2025)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Dipok Kumer Shill's research focuses on viroinformatics approaches to investigate antiviral activity and vaccine development. He has explored the potential antiviral properties of S-Adenosyl-L-Homocysteine against Dengue Virus Serotype-3, employing a viroinformatics-based method. Shill has also been involved in the development and validation of standardized pseudotyped virus-based neutralization assays. These assays are designed to assess the neutralizing activity of candidate Nipah virus vaccines. His work also touches upon Gram-negative bacterial infections, with a focus on *Stenotrophomonas maltophilia*, and the study of anti-bacterial agents, including Trimethoprim and Sulfamethoxazole. Shill's scholarship metrics include an h-index of 3, with 5 total publications and 38 total citations.
Metrics
- h-index: 3
- Publications: 5
- Citations: 41
Selected Publications
-
Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines (2025)
Collaboration Network
Top Collaborators
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Similar Researchers
Based on overlapping research topics